Loading...

We've got a brand new version of Simply Wall St! Try it out

Aevis Victoria

DB:G5LN
Snowflake Description

Worrying balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
G5LN
DB
CHF991M
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

Aevis Victoria SA provides services to healthcare, lifestyle, and infrastructure sectors in Switzerland. The last earnings update was 73 days ago. More info.


Add to Portfolio Compare Print
G5LN Share Price and Events
7 Day Returns
-
DB:G5LN
1.2%
DE Healthcare
1.6%
DE Market
1 Year Returns
-
DB:G5LN
-27.7%
DE Healthcare
-10.8%
DE Market
G5LN Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Aevis Victoria (G5LN) - - - - - -
DE Healthcare 1.2% -8.9% -1.1% -27.7% -20.2% 30%
DE Market 1.6% -3.1% 0.4% -10.8% 9.5% 6.5%
1 Year Return vs Industry and Market
  • No trading data on G5LN.
  • No trading data on G5LN.
Price Volatility
G5LN
Industry
5yr Volatility vs Market
Related Companies

Value

 Is Aevis Victoria undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Aevis Victoria. This is due to cash flow or dividend data being unavailable. The share price is €11.3.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Aevis Victoria's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Aevis Victoria's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:G5LN PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in CHF CHF-0.11
LSE:0QO0 Share Price ** LSE (2019-06-07) in CHF CHF12.4
Germany Healthcare Industry PE Ratio Median Figure of 10 Publicly-Listed Healthcare Companies 28.49x
Germany Market PE Ratio Median Figure of 421 Publicly-Listed Companies 19.74x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Aevis Victoria.

DB:G5LN PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= LSE:0QO0 Share Price ÷ EPS (both in CHF)

= 12.4 ÷ -0.11

-110.72x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Aevis Victoria is loss making, we can't compare its value to the DE Healthcare industry average.
  • Aevis Victoria is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Aevis Victoria's expected growth come at a high price?
Raw Data
DB:G5LN PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -110.72x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Germany Healthcare Industry PEG Ratio Median Figure of 7 Publicly-Listed Healthcare Companies 1.5x
Germany Market PEG Ratio Median Figure of 270 Publicly-Listed Companies 1.5x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Aevis Victoria, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Aevis Victoria's assets?
Raw Data
DB:G5LN PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in CHF CHF4.19
LSE:0QO0 Share Price * LSE (2019-06-07) in CHF CHF12.4
Germany Healthcare Industry PB Ratio Median Figure of 12 Publicly-Listed Healthcare Companies 1.55x
Germany Market PB Ratio Median Figure of 576 Publicly-Listed Companies 1.77x
DB:G5LN PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= LSE:0QO0 Share Price ÷ Book Value per Share (both in CHF)

= 12.4 ÷ 4.19

2.96x

* Primary Listing of Aevis Victoria.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Aevis Victoria is overvalued based on assets compared to the DE Healthcare industry average.
X
Value checks
We assess Aevis Victoria's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Aevis Victoria has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Aevis Victoria expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Aevis Victoria has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
8.7%
Expected Healthcare industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Aevis Victoria expected to grow at an attractive rate?
  • Unable to compare Aevis Victoria's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Aevis Victoria's earnings growth to the Germany market average as no estimate data is available.
  • Unable to compare Aevis Victoria's revenue growth to the Germany market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
DB:G5LN Future Growth Rates Data Sources
Data Point Source Value (per year)
Germany Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 8.7%
Germany Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 5.8%
Germany Market Earnings Growth Rate Market Cap Weighted Average 12.3%
Germany Market Revenue Growth Rate Market Cap Weighted Average 5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:G5LN Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CHF Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:G5LN Future Estimates Data
Date (Data in CHF Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
DB:G5LN Past Financials Data
Date (Data in CHF Millions) Revenue Cash Flow Net Income *
2018-12-31 577 16 -9
2018-09-30 572 34 -11
2018-06-30 568 52 -14
2018-03-31 575 56 -7
2017-12-31 583 60 -1
2017-09-30 569 47 4
2017-06-30 556 34 8
2017-03-31 537 45 5
2016-12-31 517 56 2
2016-09-30 513 56 5
2016-06-30 509 55 8
2016-03-31 509 46 6

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Aevis Victoria is high growth as no earnings estimate data is available.
  • Unable to determine if Aevis Victoria is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:G5LN Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Aevis Victoria Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:G5LN Future Estimates Data
Date (Data in CHF Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
DB:G5LN Past Financials Data
Date (Data in CHF Millions) EPS *
2018-12-31 -0.11
2018-09-30 -0.15
2018-06-30 -0.18
2018-03-31 -0.10
2017-12-31 -0.01
2017-09-30 0.05
2017-06-30 0.11
2017-03-31 0.07
2016-12-31 0.03
2016-09-30 0.07
2016-06-30 0.11
2016-03-31 0.08

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Aevis Victoria will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Aevis Victoria's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  2. Aevis Victoria's competitive advantages and company strategy can generally be found in its financial reports archived here.
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Aevis Victoria's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Aevis Victoria has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Aevis Victoria performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Aevis Victoria's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Aevis Victoria does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Aevis Victoria's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Aevis Victoria's 1-year growth to the DE Healthcare industry average as it is not currently profitable.
Earnings and Revenue History
Aevis Victoria's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Aevis Victoria Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:G5LN Past Revenue, Cash Flow and Net Income Data
Date (Data in CHF Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 577.13 -8.66 27.56
2018-09-30 572.48 -11.29 25.99
2018-06-30 567.83 -13.93 24.41
2018-03-31 575.17 -7.43 24.53
2017-12-31 582.51 -0.92 24.64
2017-09-30 569.40 3.63 24.79
2017-06-30 556.29 8.19 24.94
2017-03-31 536.70 5.25 24.41
2016-12-31 517.12 2.31 23.88
2016-09-30 513.26 5.10 24.56
2016-06-30 509.41 7.90 25.25
2016-03-31 508.75 5.83 25.62
2015-12-31 508.09 3.77 25.99
2015-09-30 504.40 3.39 28.73
2015-06-30 500.70 3.02 31.46
2015-03-31 492.78 4.39 27.99
2014-12-31 484.85 5.75 24.53
2014-09-30 464.88 6.16 21.02
2014-06-30 444.92 6.56 17.51
2014-03-31 421.88 7.62 17.51
2013-12-31 398.85 8.68 17.51
2013-09-30 377.60 8.03 14.09
2013-06-30 356.34 7.39 10.67
2013-03-31 331.57 5.36 15.69
2012-12-31 306.79 3.33 20.70
2012-09-30 271.95 1.61 20.85
2012-06-30 237.10 -0.10 20.99

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Aevis Victoria has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • Aevis Victoria used its assets less efficiently than the DE Healthcare industry average last year based on Return on Assets.
  • It is difficult to establish if Aevis Victoria improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Aevis Victoria's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Aevis Victoria has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Aevis Victoria's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Aevis Victoria's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Aevis Victoria's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Aevis Victoria's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Aevis Victoria's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Aevis Victoria Company Filings, last reported 5 months ago.

DB:G5LN Past Debt and Equity Data
Date (Data in CHF Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 445.03 1,082.84 34.37
2018-09-30 445.03 1,082.84 34.37
2018-06-30 384.43 1,080.90 9.36
2018-03-31 384.43 1,080.90 9.36
2017-12-31 378.16 1,053.84 33.30
2017-09-30 378.16 1,053.84 33.30
2017-06-30 401.32 1,024.18 9.00
2017-03-31 401.32 1,024.18 9.00
2016-12-31 381.50 1,033.37 25.04
2016-09-30 381.50 1,033.37 25.04
2016-06-30 304.90 855.06 8.18
2016-03-31 304.90 855.06 8.18
2015-12-31 300.55 821.37 13.07
2015-09-30 300.55 821.37 13.07
2015-06-30 307.56 747.04 22.62
2015-03-31 307.56 747.04 22.62
2014-12-31 319.20 734.53 48.57
2014-09-30 319.20 734.53 48.57
2014-06-30 318.93 622.49
2014-03-31 318.93 622.49
2013-12-31 232.92 570.34 29.07
2013-09-30 232.92 570.34 29.07
2013-06-30 171.08 352.32
2013-03-31 171.08 352.32
2012-12-31 161.54 418.17 9.80
2012-09-30 161.54 418.17 9.80
2012-06-30 41.29 74.89
  • Aevis Victoria's level of debt (243.3%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (244.1% vs 243.3% today).
  • Debt is not well covered by operating cash flow (1.5%, less than 20% of total debt).
  • Aevis Victoria is making a loss, therefore interest payments are not well covered by earnings.
X
Financial health checks
We assess Aevis Victoria's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Aevis Victoria has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Aevis Victoria's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Aevis Victoria dividends.
If you bought €2,000 of Aevis Victoria shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Aevis Victoria's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Aevis Victoria's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:G5LN Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Germany Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 9 Stocks 1.7%
Germany Market Average Dividend Yield Market Cap Weighted Average of 326 Stocks 3.2%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.4%
Germany Top 25% Dividend Yield 75th Percentile 3.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:G5LN Future Dividends Estimate Data
Date (Data in CHF) Dividend per Share (annual) Avg. No. Analysts

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Aevis Victoria has not reported any payouts.
  • Unable to verify if Aevis Victoria's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Aevis Victoria's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Aevis Victoria has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Aevis Victoria's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Aevis Victoria afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Aevis Victoria has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Aevis Victoria's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Dino Cauzza
AGE 46
TENURE AS CEO 1.1 years
CEO Bio

Mr. Dino Cauzza has been Chief Executive Officer of Swiss Medical Network at Aevis Victoria SA since May 01, 2018. Mr. Cauzza joined Swiss Medical Network in April 2017 as Delegate of the Board of its subsidiary GSMN Ticino SA, operating Clinica Sant’Anna and Clinica Ars Medica. He benefits of a long experience in the healthcare sector in Switzerland. He worked for many years at Ente Ospedaliero Cantonale (EOC), first as Chief Internal Auditor and then as Chief Financial Officer. He obtained a license in economics (lic. oec. HSG) at the University of St. Gallen and qualified as a chartered accountant. Founder of the consultancy firm Alameda SA, he is also a Board member of several companies, mainly in Ticino.

CEO Compensation
  • Insufficient data for Dino to compare compensation growth.
  • Insufficient data for Dino to establish whether their remuneration is reasonable compared to companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the Aevis Victoria management team in years:

1.1
Average Tenure
51.5
Average Age
  • The average tenure for the Aevis Victoria management team is less than 2 years, this suggests a new team.
Management Team

Antoine Hubert

TITLE
Delegate of the Board
COMPENSATION
CHF1M
AGE
52

Gilles Frachon

TITLE
Chief Financial Officer
AGE
68
TENURE
7.1 yrs

Daniel Jandric

TITLE
COO & CEO of Infracore
AGE
41
TENURE
1.1 yrs

Zeynep Berdoz

TITLE
Chief People & Information Officer
AGE
51
TENURE
0.4 yrs

Séverine Van der Schueren

TITLE
Chief Administrative Officer
AGE
48
TENURE
6.9 yrs

Pierre-Olivier Haenni

TITLE
Managing Director
AGE
53
TENURE
6.7 yrs

Dino Cauzza

TITLE
Chief Executive Officer of Swiss Medical Network
AGE
46
TENURE
1.1 yrs

Raouf Finan

TITLE
Chief Executive Officer of Victoria - Jungfrau Collection
AGE
54
TENURE
0.7 yrs
Board of Directors Tenure

Average tenure and age of the Aevis Victoria board of directors in years:

9.4
Average Tenure
62.5
Average Age
  • The tenure for the Aevis Victoria board of directors is about average.
Board of Directors

Christian Wenger

TITLE
Chairman of the Board
COMPENSATION
CHF103K
AGE
54
TENURE
6.9 yrs

Raymond Loretan

TITLE
Vice Chairman of the Board
AGE
63
TENURE
12.6 yrs

Antoine Hubert

TITLE
Delegate of the Board
COMPENSATION
CHF1M
AGE
52
TENURE
10 yrs

Antoine Kohler

TITLE
Non-Executive Director
COMPENSATION
CHF91K
AGE
62
TENURE
11 yrs

Cédric George

TITLE
Non-Executive Director
COMPENSATION
CHF53K
AGE
66
TENURE
8.8 yrs

Michel Reybier

TITLE
Non-Executive Director
COMPENSATION
CHF53K
AGE
73
TENURE
8 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Aevis Victoria's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Aevis Victoria has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Aevis Victoria SA provides services to healthcare, lifestyle, and infrastructure sectors in Switzerland. The company operates through Hospitals, Hospitality, Telemedicine, and Real Estate segments. It operates 17 hospitals with 1,111 beds; manages 4 luxury hotels; and owns and rents 47 healthcare and hospitality related real estate properties with a total rentable surface of 216,674 sqm. The company also provides ambulance and day clinic services. In addition, it engages in the aesthetic hospital, patient hotel, real estate management, stem cells, cosmetics, and publishing businesses, as well as organizes seminars. The company was formerly known as AEVIS Holding SA and changed its name to Aevis Victoria SA in June 2015. The company is headquartered in Fribourg, Switzerland. Aevis Victoria SA is a subsidiary of M.R.S.I. Medical Research, Services & Investments S.A.

Details
Name: Aevis Victoria SA
G5LN
Exchange: DB
Founded:
CHF885,768,287
77,419,205
Website: http://www.aevis.com
Address: Aevis Victoria SA
Rue Georges-Jordil 4,
Fribourg,
Fribourg, 1700,
Switzerland
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
LSE 0QO0 Registered Shares London Stock Exchange GB CHF 05. Jul 1999
BATS-CHIXE AEVSZ Registered Shares BATS 'Chi-X Europe' GB CHF 05. Jul 1999
DB G5LN CHF1 (POST SUBD) Deutsche Boerse AG DE EUR 06. Jun 2019
SWX AEVS CHF1 (POST SUBD) SIX Swiss Exchange CH CHF 06. Jun 2019
Number of employees
Current staff
Staff numbers
2,848
Aevis Victoria employees.
Industry
Health Care Facilities
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/10 00:21
End of day share price update: 2019/06/07 00:00
Last estimates confirmation: 2019/03/29
Last earnings filing: 2019/03/29
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.